Item 7.01 Regulation FD.
On
The information within this report, including Exhibit 99.1 to this Current
Report on Form 8-K, shall not be deemed to be "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of
1933, as amended. The information contained in this report and in the
accompanying Exhibit 99.1 shall not be incorporated by reference into any
registration statement or other document filed by
Item 9.01. Financial Statements and Exhibits
(d) Exhibits Exhibit Number Exhibit Title or Description 99.1 Press release issued byAnaptysBio, Inc. regarding ANB032 (anti-BTLA agonist) top-line phase 1 data, datedApril 27, 2022 . 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source